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Abstract 
 
Background: TNF-α as a pro-inflammatory cytokine plays a key role in host defense against tuberculosis (TB). 
Presence of mutation in TNF-α gene can influence the effectiveness, performance and capability of immune 
responses against this infection. The Aim of this study was to investigate the frequency of TNF-α alleles and its 
relationship with susceptibility to TB and TNF-α gene variations. 
 
Methods: A case-control study was conducted and 103 healthy controls and 93 TB patients were enrolled. Gen-
otype of TNF-238, TNF -244, TNF-308, TNF -857 and TNF-863 were distinguished using PCR-RFLP method.  
 
Results: TNF-857 and TNF-863 were in high frequency mutation regions in a population level, and a significant 
difference at TNF-857 was noticed between the two groups of case and control. 
 
Conclusion: Presence of mutation in TNF-857 region probably increases the host susceptibility to mycobacterial 
infection. Genotyping of these regions in combination with other factors can be used for screening of high risk 
persons. According to high distribution of mutations in TNF-857 and TNF-863 regions, further studies on association 
of these regions is suggested. 
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Introduction 
 
Tuberculosis (TB) is now among the most common 
infections which causes death in more than 2.000.000 
patients annually.
1 Approximately one-third of world 
population is infected with Mycobacterium tuberculo-
sis (M. tuberculosis), but the risk of developing dis-
ease ranges from 5-10%.
1,2 This suggest that besides 
the Mycobacteria itself, the host genetic factor may 
an important factor for differences in host susceptibil-
ity to TB. Recent studies have shown that there are 
individual differences in susceptibility to TB and eve-
ryone who is exposed to M. tuberculosis does not be-
come infected. These differences might be due to host 
factors, especially host genes which will influence the 
susceptibility, severity and outcome of the disease.
2,3 
Cell-mediated immunity (CMI) is considered as a 
defensive mechanism against intra-cellular pathogens 
similar to Leishmania  and M. tuberculosis.
4 T-cells 
are the major effectors of CMI with the set of secreted 
cytokines that have a prominent role in the host de-
fense against Mycobacterial infection.
4,5 Among these 
cytokines, tumor necrosis factor-α (TNF-α) has mul-
tiple roles in the defense and the pathological re-
sponse to TB.
6 TNF-α has immunoregulatory proper-
ties and  synergistic effects in addition to interferon-
gamma (IFN-γ) in activation of macrophage and initi-
ation of pro-inflammatory responses.
7,8 On the other 
hand, systemic spillover of TNF-α may account for 
unwanted inflammatory effects like fever and ma-
laise.
8 TNF-α  gene that encode the TNF-a cytokine is 
located within the major histocompatibility complex 
Class III (MHC class III) region at the short arm of 
chromosome 6 and its production is controlled both 
transcriptionally and post-transcriptionally.
9 Investi-
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gators have shown that mutation in this region would 
influence promoter activity or DNA and pre-mRNA 
conformation.
10 Among studied mutations, the  single 
nucleotide polymorphisms (SNPs) are the most com-
mon genetic variation  that occur at a frequency of ap-
proximately 1 in 1000 bp throughout the genome.
11 
Polymorphisms in TNF-a gene have been associated in 
susceptibility to tuberculosis in different ethnic groups 
but the results have been inconclusive.
12-22 This work 
was conducted to study the -238, -244, -308, -857 and -
863 TNF-α gene polymorphisms with respect to geno-
type and allele frequency distribution in patients with 
pulmonary tuberculosis among Iranian population to 
determine the association with tuberculosis. 
 
 
Materials and Methods 
 
Ninety three pulmonary tuberculosis patients with 
positive sputum smears and cultures that referred to 
Masih Daneshvari Hospital, National Research 
Institute of Tuberculosis and Lung Disease, Tehran, 
Iran were selected for this study. Control group 
contained 103 healthy individuals who had no history 
of tuberculosis. The study was approved by Ethics 
Committee of National Research Institute of 
Tuberculosis and Lung Disease, Iran, and all subjects 
signed inform consents. Two milliliters of peripheral 
blood were collected in EDTA containing tube and 
stored at -4°C until DNA extraction.  
Genomic DNA was extracted from peripheral 
blood leukocytes (PBLs), using the standard phenol–
chloroform procedure with slight modifications.
23 The 
polymorphisms at TNF-238, -244, -308,-857 and -863 
were determined. The primers and PCR conditions 
for each region were shown in Table 1 and 2. TNF-
238 and -244 polymorphisms were determined by the 
polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) method and the PCR 
product was digested directly with 10 U of Bgl II and 
Bsaj I restriction enzymes (Fermentas), respectively.
24 
The TNF-308, -857 and -863 polymorphisms were 
also determined by PCR-RFLP method. We used Nco 
I as the restriction enzyme for TNF-308 and Tai I as 
the restriction enzyme for TNF-857 and TNF-863.
24,25 
Digested PCR products were run on 8% polyacrylamide 
gel which was stained with silver-nitrate and digestion 
pattern was analyzed. The digest pattern of each 
polymorphism is illustrated in Table 3. 
 
Table 2: The primers sequences used for amplifying 
the TNF-α regions.
Regions Primer sequences 
TNF -
238/-244 
5'- CCTCAAGGACTCAGCTTTCGT -3' 
5'- ACACTCCCCATCCTCCCACATC -3' 
TNF -308  5'- AGGCAATAGGTTTTGAGGGCCAT -3' 
5'- TCCTCCCTGCTCCGATTCCG -3' 
TNF -857  5'- GGCTCTGAGGAATGGGTTAC -3' 
5'- CCTCTACATGGCCCTGTCTAC -3' 
TNF -863  5'- GGCTCTGAGGAATGGGTTAC -3' 
5'- CCTCTACATGGCCCTGTCTAC -3' 
All statistical analyses were performed using 
Table 1: PCR Conditions used for amplifying the TNF-α regions.
TNF -863  TNF -857 TNF -308  TNF -238/-244 
94° for 4 min 1 cycle  94° for 4 min 1 cycle 94° for 4 min 1 cycle  94° for 3 min  1 cycle 
94° for 45 sec  30 cycle  94° for 40 sec   30 cycle  94° for 60 sec   30 cycle  94° for 40 sec   30 cycle 
53° for 45 sec  56.5° for 40 sec   56° for 60 sec   53° for 40 sec  
72° for 60 sec 72° for 55 sec  72° for 60 sec  72° for 55 sec  
72° for 6 min  1 cycle  72° for 6 min  1 cycle  72° for 8 min  1 cycle  72° for 6 min  1 cycle 
 
 
Table 3: Digest pattern of each SNP on polyacrylamide gel electrophoresis.
Digest pattern Enzyme PCR product Size SNP 
A (216, 23 bp ) 
G (239 bp ) 
Bgl II  239 bp  (G →A)  TNF-238 
G (169,78 bp ) 
A (239 ) 
Bsaj I  239 bp  (G →A)  TNF-244 
G (87, 20 bp ) 
A (107 bp ) 
Nco I  107 bp  (G →A)  TNF-308 
C (109, 18 bp ) 
T (127 bp ) 
Tai I  127 bp  (C →T)  TNF-857 
A (105, 21 bp ) 
C (126 bp ) 
Tai I  126 bp  (C →A)  TNF-863 
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SPSS software (version 16, Chicago, IL, USA). Chi-
Square test was utilized to define any statistically sig-
nificant differences among polymorphic allele or 
genotype between the two case and control groups. P 
values were calculated using Fisher Exact test 
(p<0.05 was considered statistically significant). The 
data were analyzed for their fitness to Hardy-
Weinberg equilibrium. 
 
 
Results 
 
The mean age was 50.04 years for patients and 38.75 
years for controls, and the two groups were matched 
for gender. The mean age of cases was higher than 
controls but the difference was not significant. Geno-
type and allele frequencies in patients and healthy 
people were shown in Table 4.  
Frequency of alleles of TNF-238A, TNF-308A, TNF-857T, 
and TNF-863A in the control group were  2.4%, 7.8%, 
10.7%, and 14.1% respectively, and 4.8%, 4.8%, 
22.6%, and 14.5% for case group, respectively. No 
change was observed in the region of TNF-244. Com-
parison of genotypes between the control and case 
groups showed a significant difference at region of   
TNF-857 ; the frequency of C/T at region-857 in control 
and case groups was 17.5%  and 45.2% respectively 
(p-value < 0.001, odds: 2.4; CI 95%: 1.3-2.4). 
Table 4: Genotype and allele frequencies in patients and healthy people 
SNP   Control Patient P value
N% N %
TNF-238 Genotype   
NS
a  G/G 98  95.1  84  90.3 
G/A 5 4.9 9 9.7 
A/A 0  -  0  - 
Allele frequency   
NS  G 201 97.6 177 95.2 
A 5  2.4  9  4.8 
TNF-244 Genotype   
NS  G/G 103  100  93  100 
G/A 0  - 0  - 
A/A 0  -  0  - 
Allele frequency   
NS  G 206  100  186  100 
A -  0  -  0 
TNF-308 Genotype   
NS  G/G 87  84.5  84  90.3 
G/A 16  15.5  9  9.7 
A/A 0  -  0  - 
Allele frequency   
NS  G 190  92.2  177  95.2 
A 16  7.8  9  4.8 
TNF-857 Genotype   
0.001
  C/C 83  80.6  51  54.8 
C/T 18  17.5  42  45.2 
T/T 2  1.9  0  - 
Allele frequency   
0.002
b  C 184  89.3  144  77.4 
T 22  10.7  42  22.6 
TNF-863 Genotype   
NS  C/C 74  71.8  69  74.2 
C/A 29  28.2  21  22.6 
A/A 0  -  3  3.2 
Allele frequency   
NS  C 177  85.9  159  85.5 
A 29  14.1  27  14.5 
aNS: Nonsignificant, 
b odds: 2.4, C.I 95% (1.3-4.4) 
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In regions of TNF-238, TNF-244 , TNF-308  and TNF-863, 
no significant relationship was observed between the 
two groups. The distribution of alleles of regions -238, 
-308, -857 and -863 in the control group showed a 
good fitness using the Hardy–Weinberg equilibrium. 
 
 
Discussion  
 
Many single nucleotide polymorphisms are detected in 
the TNF-α gene region but most of the effective poly-
morphisms on TNF-α gene expression are those which 
are located in promoter region and has been altered lev-
els of circulating TNF-α.
26,27  During recent years, the 
association between these polymorphisms and many 
illnesses including a wide range of infectious and auto-
immune diseases as well as some prevalent cancers have 
been studied through which some relationships were 
defined concerning the susceptibility to diseases and the 
severity of them.
28-30 TNF-α is an important mediator in 
inflammatory responses and in mice deficient in TNF-α 
was shown to fail to form organized granuloma, which 
resulted in widespread dissemination of M. tuberculosis 
and rapid death of infected animals.
31 Previous studies 
on association between TNF-α gene polymorphisms and 
tuberculosis were limited and most of them focused on-
ly on the two regions -308 and -238 with actually differ-
ent results.
3,5,12-22  
In this study, we found new association between 
TNF-857 and TB while the TNF-857 C/T genotype 
had significantly a higher frequency in TB patients. 
However, Delgado did not find any significant asso-
ciation between TB and TNF-857 in Cambodian pop-
ulation.
16 We also found no significant association 
between the TNF-238, TNF-308 polymorphisms with 
TB, which is consistent with some previous studies.
15-
19 Selvaraj showed that none of the TNF-238 and 
TNF-308 polymorphisms were associated with pul-
monary TB. Also, Ates did not notice any significant 
association between TNF-238, TNF-308 and TNF-
376 polymorphisms and TB.
15-19 In this context, some 
researchers noted that the TNF-308 G/G significantly 
decreased among TB cases.
5,12,14  Bikmaeva reported 
that the frequency of allele TNF-308/A in tuberculo-
sis patients was significantly higher than in con-
trols.
5,12,14 Some studies considered the presence of 
TNF-238A as a risk factor for susceptibility to 
TB.
13,14 Correa reported that the TNF-238A allele was 
protective for autoimmunity but represented a suscep-
tibility factor for TB.
13,14  
The associations between TNF-a production and 
TNF promoter polymorphisms are controversial. 
Wilson's study showed that TNF-308A is a much 
stronger transcriptional activator than TNF-308G in 
the human B cell line, and the TNF-308 polymor-
phisms have direct effects on TNF gene regula-
tion.
32 However, Uglialoro's study showed that the 
TNF-308 polymorphisms did not affect the TNF 
gene expression in activated lymphocytes.
33  Fur-
thermore, There were no significant association 
between TNF-863 polymorphisms and TB in this 
study, but this region showed high diversity of al-
lele among studied population, which is similar to 
Delgado's results in combodia.
16  The polymor-
phisms at position TNF-244 could not be detected 
in the present study, which is consistent with Yen's 
study in Taiwan.
24  
These divergent findings may be due to ethnical dif-
ferences in various populations that is why the studies 
that were performed in healthy controls showed allele 
diversities.
34-38  Generally, the single nucleotide poly-
morphisms in several candidate genes have been linked 
to relatively increased risk of TB.
28-30,39 Although, stud-
ies with higher number of cases might lead to more def-
inite and reliable results regarding the relationship be-
tween TNF-α gene polymorphism and pulmonary tu-
berculosis. However, the importance of other genetical 
factors such as VDR (Vitamin D Receptor), and 
NRAMP1 (natural resistance-associated macrophage 
protein-1) should not be ignored.  
We can conclude that TNF-857C/T genotype may 
be considered as a genetic marker that influences the 
susceptibility to tuberculosis in studied Iranian 
populations. Therefore, more comprehensive studies 
on -857 and -863 allele diversity of TNF gene is 
necessary.  
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